ARCA biopharmaABIO 
$26.10-1.42%24h
-1.42%24h
Global rank
Market cap$376.18M
Change 7d4.32%
YTD Performance1435.00%
SP500 benchmarkOutperform
P/E-70.53
P/S0
Revenue$0
Earnings-$5.34M
Dividend yield-
EPS for ARCA biopharma (ABIO)
ARCA biopharma has an EPS of $-0.37. In 2022, the company made an earnings per share (EPS) of $-0.69. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for ABIO
-
Value:-
EPS history for ARCA biopharma from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.37 | -46.38% |
| 2022 | -$0.69 | -50.36% |
| 2021 | -$1.39 | -32.85% |
| 2020 | -$2.07 | - |
View the highest EPS stocks
